State Of Alaska, Department Of Revenue Acadia Pharmaceuticals Inc Transaction History

State Of Alaska, Department Of Revenue

  • $8.95 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 10, 2018
SELL
$15.07 - $22.34 $136,232 - $201,953
-9,040 Closed
0 $0
Q1 2018

Apr 19, 2018
BUY
$22.47 - $32.33 $39,097 - $56,254
1,740 Added 23.84%
9,040 $203,000
Q4 2017

Jan 19, 2018
BUY
$26.84 - $39.14 $195,932 - $285,722
7,300
7,300 $219,000

Others Institutions Holding ACAD

# of Institutions
315
Shares Held
164M
Call Options Held
855K
Put Options Held
350K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email